Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Clinical trial NCT06772168 · RECRUITING
Trial details
- NCT number
- NCT06772168
- Sponsor
- CMG Pharmaceutical Co. Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2026-11-04
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.